活性激素的效率链接在尼古丁受体中结合和关闭
Dinesh C Indurthi1, Anthony Auerbach1
1Department of Physiology and Biophysics, University at Buffalo, State University of New York, Buffalo, United States.
eLife
|July 3, 2023
概括
受体关口效率 (η) 量化了激动剂的结合能量如何启动受体激活. 五个不同的效率类表明了五个独特的结合位结构,将激动体结合与受体功能联系起来.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 受体在休息状态 (C) 和活跃状态 (O) 之间过渡,以发出信号.
- 激动剂的结合能量 (O-C) 决定了最大的受体反应.
- 尼古丁受体利用效率 (η) 来将结合能量与关口联系起来.
研究的目的:
- 调查激动剂结合能和受体结合效率 (η) 之间的关系.
- 根据效率类识别受体结合部位的不同结构状态.
- 为了阐明效率 (η) 如何校准蛋白质中的全转换.
主要方法:
- 对53种受体突变中的23种激动剂的度-反应曲线的分析.
- 估计和分类的受体门效率 (η) 值.
- 疗效,亲和力和效率等级之间的相关性分析.
主要成果:
- 受体效率 (η) 分为五个不同的类别:0.56 (17%),0.51 (32%),0.45 (13%),0.41 (26%),和0.31 (12%).
- 这些类意味着有五种不同的C与O结合点结构对.
- 在每个类中观察到有效性和亲和力之间的线性相关性,被多个类的存在掩盖.
结论:
- 门效率 (η) 作为激动剂结合和受体激活之间的关键联系.
- 识别的效率类为受体结合部位的多重结构构造提供了证据.
- 效率 (η) 校准了受体蛋白的全转变通路中的关键步骤.
相关概念视频
Cholinergic Receptors: Nicotinic
2.9K
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
2.9K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.3K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.3K
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
2.3K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.3K
Drug-Receptor Interaction: Agonist
2.6K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.6K
Drug-Receptor Interactions
5.4K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.4K
Drugs Acting on Autonomic Ganglia: Stimulants
1.4K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.4K


